Professor Terry Nolan is a paediatrician and clinical epidemiologist. He is a medical graduate of the University of Western Australia, trained in paediatrics at the Royal Children's Hospital in Melbourne and at the Montréal Children's Hospital, with a PhD in in epidemiology and biostatistics at McGill University in Montréal. He established the Clinical Epidemiology and Biostatistics Unit at the Royal Children's Hospital in 1989, was promoted to Professor in 1999 and became Deputy Head of Paediatrics within the School of Medicine. In 2001, he was appointed Foundation Head of the School of Population Health at the University of Melbourne (renamed Melbourne School of Population and Global Health in 2013 with incorporation of Nossal Institute for Global Health). He established the Vaccination and Immunisation Research Group (VIRGo) in the early 1990s. His research has been in clinical paediatrics in adjustment to chronic illness and in incontinence, and in immunisation and clinical trials of new vaccines. His expertise relates to immunisation, pandemic planning and response, clinical trials, research investment in clinical and population health research, research quality, injury control and other areas. He is the immediate past Chair of the Australian Technical Advisory Group on Immunisation (ATAGI), was a member and then Deputy Chair of the National Health and Medical Research Council's (NHMRC) Research Committee over nine years. He has more than 215 publications including 200 in refereed journals and a track record of over $40 million in project grant funding. He is a member of the Australian Academy of Science's National Committee for Medicine, and of SAGE, the World Health Organisation's main advisory group on vaccines and immunisation.
Professor Terry Nolan is a paediatrician and clinical epidemiologist. He is a medical graduate of the University of Western Australia, trained in paediatrics at the Royal Children's Hospital in Melbourne and at the Montréal Children's Hospital, with...
Professor Terry Nolan is a paediatrician and clinical epidemiologist. He is a medical graduate of the University of Western Australia, trained in paediatrics at the Royal Children's Hospital in Melbourne and at the Montréal Children's Hospital, with a PhD in in epidemiology and biostatistics at McGill University in Montréal. He established the Clinical Epidemiology and Biostatistics Unit at the Royal Children's Hospital in 1989, was promoted to Professor in 1999 and became Deputy Head of Paediatrics within the School of Medicine. In 2001, he was appointed Foundation Head of the School of Population Health at the University of Melbourne (renamed Melbourne School of Population and Global Health in 2013 with incorporation of Nossal Institute for Global Health). He established the Vaccination and Immunisation Research Group (VIRGo) in the early 1990s. His research has been in clinical paediatrics in adjustment to chronic illness and in incontinence, and in immunisation and clinical trials of new vaccines. His expertise relates to immunisation, pandemic planning and response, clinical trials, research investment in clinical and population health research, research quality, injury control and other areas. He is the immediate past Chair of the Australian Technical Advisory Group on Immunisation (ATAGI), was a member and then Deputy Chair of the National Health and Medical Research Council's (NHMRC) Research Committee over nine years. He has more than 215 publications including 200 in refereed journals and a track record of over $40 million in project grant funding. He is a member of the Australian Academy of Science's National Committee for Medicine, and of SAGE, the World Health Organisation's main advisory group on vaccines and immunisation.

Top Publications

  • Rowe, SL, Stephens, N, Cowie, BC, Nolan, T, Leder, K, Cheng, AC. Use of data linkage to improve communicable disease surveillance and control in Australia: existing practices, barriers and enablers. Australian and New Zealand Journal of Public Health 43(1) : 33 -40 2019
    view publication
  • McHugh, L, Marshall, HS, Perrett, KP, Nolan, T, Wood, N, Lambert, SB, Richmond, P, Ware, RS, Binks, P, Binks, MJ, et al. The Safety of Influenza and Pertussis Vaccination in Pregnancy in a Cohort of Australian Mother-Infant Pairs, 2012–2015: The FluMum Study. Clinical Infectious Diseases 68(3) : 402 -408 2019
    view publication
  • Wilder-Smith, A, Hombach, J, Ferguson, N, Selgelid, M, O'Brien, K, Vannice, K, Barrett, A, Ferdinand, E, Flasche, S, Guzman, M, et al. Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine. The Lancet Infectious Diseases 19(1) : e31 -e38 2019
    view publication
  • Nolan, T, O’Ryan, M, Santolaya, ME, De Looze, F, Marshall, H, Richmond, P, Henein, S, Rheault, P, Heaton, K, Perrett, K, et al. 152. Protective Antibody Levels 7.5 Years After Primary Vaccination in Adolescence With a Recombinant, 4-Component, Meningococcal Serogroup B Vaccine (4CMenB) and Response to a Booster Dose in Adolescents and Young Adults: Phase IIIb Clinical Findings. Open Forum Infectious Diseases 5(suppl_1) : s11 -s11 2018
    view publication
  • Wood, N, Nolan, T, Marshall, H, Richmond, P, Gibbs, E, Perrett, K, McIntyre, P. Immunogenicity and Safety of Monovalent Acellular Pertussis Vaccine at Birth. JAMA Pediatrics 172(11) : 1045 -1052 2018
    view publication

Page 8 of 39